Master’s Degree Awarded to Mr. Sami Ahmed Ali Quait in Hematology and Laboratory Blood Transfusion

Mr. Sami Ahmed Ali Quait was awarded a Master’s degree in the major of Hematology and Laboratory Blood Transfusion with a grade of (Very Good) and an average of (89%) for his thesis titled ” Prevalence of Coagulopathy and Associated Factors among Type II Diabetes Mellitus Patients in Hospitals of Sana’a City -Yemen,” which was submitted to Department of Hematology and Laboratory Blood Transfusion, Faculty of Medicine and Health Sciences – Sana’a University. The defense was held on Tuesday, February 17, 2026.
The MA Viva-voce Committee, which was formed based on a resolution issued by the Post-Graduate Studies and Scientific Research Council, consisted of the following members:
# Committee Members Designation University Position
1 Prof. Lutfi Abdulsalam Al-Maqtari Internal Examiner Sana’a Uni. Chair
2 Assoc. Prof. Mohammed Ahmed Hajar Main Supervisor Sana’a Uni. Member
3 Assoc. Prof. Fouad Ahmed Balkam External Examiner Hodeidah Uni. Member

The study aimed to provide critical insights into the hematological complications of diabetes by:
• Assessing the correlation between demographic factors (age, gender, and educational level) and coagulopathy among Type II Diabetes Mellitus patients.
• Evaluating the relationship between lifestyle and clinical factors—including regular physical exercise, duration of diabetes, duration of medication, blood pressure, and Body Mass Index (BMI)—with the development of coagulopathy.

The study highlighted several significant findings:
• The prevalence of blood coagulopathy among Type II Diabetes Mellitus patients in Sana’a hospitals is alarmingly high, reaching 54.7%.
• The study identified prolonged Prothrombin Time (PT) and prolonged Activated Partial Thromboplastin Time (APTT) as the most frequent coagulation disorders.
• Findings underscore the vital importance of coagulation markers as key indicators associated with the overall health status of Type II Diabetes Mellitus patients.
The study concluded with several key recommendations, notably:
• Integrate coagulation tests (PT and APTT) and platelet counts into standard evaluation protocols for Type II Diabetes Mellitus patients.
• Conduct further research to identify and address the specific clotting factor deficiencies responsible for prolonged PT and APTT.
• Implement long-term studies to confirm the predictive value of platelet indices, the Immature Platelet Fraction (IPF), and fibrinogen as biomarkers for cardiovascular events and microvascular complications among Yemeni diabetic patients.

The study was examined and recommended by the Viva-Voce Committee for acceptance and approval. The defense was attended by a number of academics, researchers, interested individuals, in addition to the candidate’s colleagues and family members.